Current Ratio of ARS Pharmaceuticals, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ARS Pharmaceuticals, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • ARS Pharmaceuticals, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 853%, a 72% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

ARS Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 853% -2160% -72% 30 Sep 2025
Q2 2025 996% -2849% -74% 30 Jun 2025
Q1 2025 1435% -2067% -59% 31 Mar 2025
Q4 2024 1960% -1024% -34% 31 Dec 2024
Q3 2024 3013% +153% +5.3% 30 Sep 2024
Q2 2024 3845% +193% +5.3% 30 Jun 2024
Q1 2024 3502% -45% -1.3% 31 Mar 2024
Q4 2023 2984% -48% -1.6% 31 Dec 2023
Q3 2023 2861% +615% +27% 30 Sep 2023
Q2 2023 3652% +1852% +103% 30 Jun 2023
Q1 2023 3548% +1710% +93% 31 Mar 2023
Q4 2022 3032% +847% +39% 31 Dec 2022
Q3 2022 2245% -514% -19% 30 Sep 2022
Q2 2022 1800% 30 Jun 2022
Q1 2022 1838% 31 Mar 2022
Q4 2021 2185% 31 Dec 2021
Q3 2021 2759% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.